Related Experiment Video
Updated: Mar 20, 2026

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage
Ruxia Wang1, Hongchao Jiao1, Jingpeng Zhao1
1Department of Animal Science, Shandong Agricultural University, Shandong Key Lab for Animal Biotechnology and Disease Control, Taian, Shandong, 271018, P. R. China.
Abstract:
Myostatin, a member of the TGF-β superfamily of secreted proteins, is expressed primarily in skeletal muscle. It negatively regulates muscle mass and is associated with glucocorticoid-induced muscle atrophy. However, it remains unclear whether myostatin is involved in glucocorticoid-induced muscle protein turnover. The aim of the present study was to investigate the role of myostatin in protein metabolism during dexamethasone (DEX) treatment. Protein synthesis rates and the expression of the genes for myostatin, ubiquitin-proteasome atrogin-1, MuRF1, FoxO1/3a and mTOR/p70S6K were determined. The results show that DEX decreased (P<0.05) protein synthesis rates while increasing the abundance of myostatin. DEX increased (P<0.05) the level of phospho-FoxO1/3a (Thr 24/32) and the expression of MuRF1. In contrast, DEX treatment had no detectable effect on atrogin-1 protein levels (P>0.05). The phosphorylation levels of mTOR and p70S6K were decreased by DEX treatment (P<0.05). Follistatin treatment inhibited the DEX-induced increase in myostatin (P<0.05) and the activation of phosphor-FoxO1/3a (Thr 24/32) (P< 0.05) and MuRF1 (P<0.05). Follistatin treatment had no influence on the protein synthesis rate or on the phosphorylation levels of mTOR (Ser 2448) and p70S6K (Thr 389) (P> 0.05). In conclusion, the present study suggests that the myostatin signalling pathway is associated with glucocorticoid-induced muscle protein catabolism at the beginning of exposure. Myostatin is not a main pathway associated with the suppression of muscle protein synthesis by glucocorticoids.
Insights
Glucocorticoids like dexamethasone increase myostatin, a protein regulating muscle mass, and promote muscle protein breakdown. However, myostatin does not significantly suppress muscle protein synthesis during short-term dexamethasone treatment.
Area of Science:
- Muscle physiology and molecular biology
- Endocrinology and metabolism
Background:
- Myostatin is a key regulator of skeletal muscle mass.
- Glucocorticoids, such as dexamethasone (DEX), are known to induce muscle atrophy.
- The precise role of myostatin in glucocorticoid-induced muscle protein turnover remains incompletely understood.
Purpose of the Study:
- To investigate the involvement of myostatin in muscle protein metabolism during dexamethasone (DEX) treatment.
- To elucidate the effects of DEX on protein synthesis, degradation pathways, and key signaling molecules.
Main Methods:
- Measurement of protein synthesis rates.
- Quantification of gene and protein expression for myostatin, atrogin-1, MuRF1, FoxO1/3a, mTOR, and p70S6K.
- Assessment of signaling pathway activation through phosphorylation.
- Intervention with follistatin to block myostatin activity.
Main Results:
- DEX decreased protein synthesis rates and increased myostatin abundance.
- DEX elevated phospho-FoxO1/3a and MuRF1 expression, but not atrogin-1.
- DEX reduced phosphorylation of mTOR and p70S6K.
- Follistatin counteracted DEX-induced increases in myostatin, phospho-FoxO1/3a, and MuRF1.
Conclusions:
- The myostatin signaling pathway is implicated in glucocorticoid-induced muscle protein catabolism early in exposure.
- Myostatin is not the primary mediator of glucocorticoid-induced suppression of muscle protein synthesis.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

